STOCK TITAN

Translational Development: Nonbinding terms for up to $135M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
425

Rhea-AI Filing Summary

Translational Development Acquisition Corp. (TDAC) and ProLogium Holding Inc. announced signed non-binding term sheets for up to $135 million in proposed investments from existing and strategic investors in connection with ProLogium’s proposed business combination with TDAC. The corrected release replaces the earlier $85 million figure. Each PIPE investment is expected to be made in common shares at $10.00 per share concurrently with closing; the proposed investments remain subject to negotiation and execution of definitive transaction documents. One strategic-partner term sheet contemplates follow-on investments after closing on terms to be agreed.

ProLogium expects to use proceeds for its Dunkirk, France gigafactory build-out, including seeking further reimbursements from the $1.5 billion French Government subsidy, and expansion into new applications. The transaction is expected to close in December 2026, subject to TDAC shareholder approval and customary closing conditions. ProLogium says the Dunkirk Phase 1 facility is designed for 4.0 GWh of production capacity, which it expects to achieve gradually by 2030.

Proposed investments Up to $135 million Non-binding term sheets; corrected amount replaces the earlier $85 million figure.
Expected investment price $10.00 per share Expected price for common shares in each PIPE investment.
Expected transaction closing December 2026 Subject to TDAC shareholder approval and other customary closing conditions.
French Government subsidy $1.5 billion ProLogium expects proceeds to support the Dunkirk build-out, including unlocking further reimbursements from the subsidy.
Dunkirk Phase 1 designed production capacity 4.0 GWh ProLogium expects to achieve this capacity gradually by 2030.
Dunkirk site maximum designed production capacity 44.0 GWh Maximum designed production capacity for the Dunkirk facility site.
PIPE investment financial
"Each PIPE investment is expected to be made in common shares"
A pipe investment is a private sale of stock or convertible securities made directly to selected investors by a company that is already publicly traded, allowing the company to raise cash quickly without a full public offering. It matters to investors because it can dilute existing share value and change ownership stakes, but also signals that the company secured financing; like a homeowner taking a quick private loan to cover a repair, it can be a sign of needed funds or investor confidence.
non-binding term sheets financial
"signing of non-binding term sheets"
A non-binding term sheet is a preliminary document that outlines the main proposed terms of a transaction—such as price, key conditions, structure, and timelines—without creating a legally enforceable obligation. It matters to investors because it signals the likely framework and intent behind a potential deal while parties negotiate details and conduct due diligence; think of it as a handshake and checklist that helps market participants assess potential impact and timing before a definitive contract is drafted.
business combination financial
"proposed business combination with TDAC"
A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.
roll-to-roll coated ceramic separator manufacturing process technical
"roll-to-roll coated ceramic separator manufacturing process"
GWh-class gigafactory technical
"ProLogium’s first GWh-class gigafactory"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much investment did TDAC and ProLogium announce?

They announced term sheets for up to $135 million in proposed investments. The corrected release replaces the earlier $85 million figure. The term sheets are non-binding and remain subject to negotiation and execution of definitive transaction documents.

At what price are the proposed TDAC and ProLogium PIPE investments expected to be made?

The investments are expected to be made at $10.00 per common share, concurrently with the closing of the proposed business combination.

When is the TDAC and ProLogium business combination expected to close?

The transaction is expected to close in December 2026, subject to approval by TDAC shareholders and other customary closing conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Filed by Prologium Holding Inc.

Pursuant to Rule 425

under the Securities Act of 1933, as amended

and deemed filed pursuant to Rule 14a-12

under the Securities Exchange Act of 1934, as amended

Subject Company: Translational Development Acquisition Corp.

Commission File No.: 001-42451

Date: November 19, 2026

On November 19, 2026, ProLogium published the following press release:

CORRECTION — ProLogium and TDAC Announce Prospective Investments of $135 Million

In a release issued under the headline “ProLogium and TDAC Announce Prospective Investments of $85 Million” today, November 18th by ProLogium Holding Inc., please note that the investments amount should have read $135 Million and not $85 Million. The corrected release follows:

Non-binding term sheets signed for up to $135 million of investment

Existing and strategic investors investing at the business combination to participate at $10.00 per share.

Proceeds expected to support the build-out of ProLogium’s Dunkirk, France gigafactory driving it to the first 4 GW of capacity, further expansion of revenue opportunities in new markets, and other general corporate purposes.

TAIPEI, Taiwan and NEW YORK, Nov. 19, 2026 (GLOBE NEWSWIRE) — ProLogium Holding Inc. (“ProLogium” or the “Company”), a global leader in next-generation lithium ceramic battery technology, and Translational Development Acquisition Corp. (“TDAC”) (Nasdaq: TDAC), a special purpose acquisition company, today announced the signing of non-binding term sheets with a number of existing and strategic investors for proposed investments totaling up to $135 million.

Under these term sheets, several existing investors in ProLogium and other strategic investors have indicated an intention to invest in connection with ProLogium’s previously announced proposed business combination with TDAC (the “Transaction). Each PIPE investment is expected to be made in common shares at $10.00 per share concurrently with the closing of the Transaction. One term sheet with a strategic partner contemplates follow-on investments after the closing of the Transaction, on terms to be agreed as part of a broader partnership plan. The proposed investments remain subject to the negotiation and execution of definitive transaction documents. ProLogium expects to use the proceeds for the build-out of its gigafactory in Dunkirk, France including unlocking further reimbursements from the $1.5bn French Government subsidy, accelerating expansion into new business applications for revenue expansion in new markets such as drones, and other general corporate purposes. The Transaction is expected to close in December 2026, subject to approval by TDAC’s shareholders and other customary closing conditions.

“These term sheets reflect the interest we are seeing from investors in ProLogium’s technology and our plans to scale production of next-generation lithium ceramic batteries. The additional capital would help us advance construction of our Dunkirk gigafactory in France and support our continued expansion into automotive, unmanned systems, AI data centers and other application markets, serving customers in Europe and globally.” said Vincent Yang, Founder and Chief Executive Officer of ProLogium.

“We are encouraged by the support from existing and strategic investors reflected in these term sheets. We are working with these investors to finalize definitive agreements as we move toward closing the Transaction,” said Michael B. Hoffman, Chairman and Chief Executive Officer of TDAC.

 

1


The original press release issued by ProLogium on November 18, 2026, under the headline “ProLogium and TDAC Announce Prospective Investments of $85 Million,” is attached below:

ProLogium and TDAC Announce Prospective Investments of $85 Million

Non-binding term sheets signed for approximately $85 million of investment

Existing and strategic investors investing at the business combination to participate at $10.00 per share.

Proceeds expected to support the build-out of ProLogium’s Dunkirk, France gigafactory driving it to the first 4 GW of capacity, further expansion of revenue opportunities in new markets, and other general corporate purposes.

TAIPEI, Taiwan and NEW YORK, Nov. 18, 2026 (GLOBE NEWSWIRE) — ProLogium Holding Inc. (“ProLogium” or the “Company”), a global leader in next-generation lithium ceramic battery technology, and Translational Development Acquisition Corp. (“TDAC”) (Nasdaq: TDAC), a special purpose acquisition company, today announced the signing of non-binding term sheets with a number of existing and strategic investors for proposed investments totaling approximately $85 million.

Under these term sheets, several existing investors in ProLogium and other strategic investors have indicated an intention to invest in connection with ProLogium’s previously announced proposed business combination with TDAC (the “Transaction). Each PIPE investment is expected to be made in common shares at $10.00 per share concurrently with the closing of the Transaction. One term sheet with a strategic partner contemplates follow-on investments after the closing of the Transaction, on terms to be agreed as part of a broader partnership plan. The proposed investments remain subject to the negotiation and execution of definitive transaction documents. ProLogium expects to use the proceeds for the build-out of its gigafactory in Dunkirk, France including unlocking further reimbursements from the $1.5bn French Government subsidy, accelerating expansion into new business applications for revenue expansion in new markets such as drones, and other general corporate purposes. The Transaction is expected to close in December 2026, subject to approval by TDAC’s shareholders and other customary closing conditions.

“These term sheets reflect the interest we are seeing from investors in ProLogium’s technology and our plans to scale production of next-generation lithium ceramic batteries. The additional capital would help us advance construction of our Dunkirk gigafactory in France and support our continued expansion into automotive, unmanned systems, AI data centers and other application markets, serving customers in Europe and globally,” said Vincent Yang, Founder and Chief Executive Officer of ProLogium.

“We are encouraged by the support from existing and strategic investors reflected in these term sheets. We are working with these investors to finalize definitive agreements as we move toward closing the Transaction,” said Michael B. Hoffman, Chairman and Chief Executive Officer of TDAC.

 

2


About Prologium Holding Inc.

Founded in 2006, Prologium Holding Inc. (“ProLogium”) is an energy innovation company dedicated to the development and manufacturing of next-generation lithium ceramic batteries, holding over 1,100 global patents (granted and pending). In 2013, ProLogium commercialized solid-state batteries, primarily for use in smartphones charging cases and since then, ProLogium has delivered in the aggregate more than 2.4 million battery products to its collaboration partners and customers, including cells used in automotive audio systems and approximately 10,000 samples for automotive applications. In 2025, ProLogium introduced superfluidized inorganic next generation lithium ceramic battery, integrating the advantages of solid-state and liquid type batteries and redefining next-generation battery technology with scalable manufacturability and cost competitiveness. In 2026, ProLogium once again received the Edison Awards Gold Award for its superfluidized inorganic next generation lithium ceramic battery technology.

With more than 13 years of manufacturing know-how, ProLogium is among the first companies to successfully commercialize a high-efficiency roll-to-roll coated ceramic separator manufacturing process and its Taoke facility announced that it was the first commercial next-generation lithium ceramic battery gigafactory to publicly display the production line—reflecting that next generation lithium ceramic batteries represent a feasible solution for scalable manufacturing rather than a laboratory project. ProLogium’s first GWh-class gigafactory, Taoke facility, is located in Taoyuan, Taiwan. In 2024, ProLogium established its first overseas R&D center in Paris-Saclay, France, providing customized technical support for the European market. ProLogium’s second battery gigafactory is located in Dunkirk, France, where groundbreaking for its Phase 1 facility took place in February 2026 and the project is proceeding to the detailed design and construction stage. The Phase 1 facility will have a designed production capacity of 4.0 GWh when complete, which ProLogium expects to achieve gradually by 2030. The Dunkirk facility site will have a maximum designed production capacity of 44.0 GWh and is intended to work closely with ProLogium’s Paris-Saclay R&D center.

About Translational Development Acquisition Corp.

Translational Development Acquisition Corp. (“TDAC”) is a blank check company incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. TDAC may pursue an acquisition opportunity in any business, industry, sector, or geographical location, and intends to focus on industries that complement its management team’s background and intends to capitalize on the ability of its management team to identify and acquire a business.

 

3


TDAC’s management team is led by Michael B. Hoffman, its chief executive officer and chairman of the board of directors, and Avanindra C. Das, chief financial officer. In addition, TDAC’s board includes E. Premkumar Reddy, Curtis T. Keith, Matthew A. Kestenbaum and Christopher Jarratt.

Important Information and Where to Find It

In connection with the business combination (the “Transaction”), ProLogium has filed a registration statement on Form F-4 with the SEC that includes a prospectus with respect to ProLogium’s securities to be issued in connection with the Transaction and a proxy statement with respect to the shareholder meeting of TDAC to vote on the Transaction. This communication, including the investment described herein, does not contain all the information that should be considered concerning the Transaction and is not intended to form the basis of any investment decision or any other decision in respect of the Transaction. Before making any voting or investment decision, shareholders of TDAC, investors and other interested persons are advised to read CAREFULLY IN their ENTIRETY, the preliminary proxy statement / prospectus (including any amendments thereto), as well as other documents filed with the SEC, because these documents will contain important information about ProLogium, TDAC and the Transaction. After the registration statement is declared effective, the definitive proxy statement / prospectus to be included in the registration statement will be mailed to shareholders of TDAC as of a record date to be established for voting on the Transaction. The preliminary and definitive proxy statement / prospectus to be included in the registration statement, once available, can also be obtained, without charge, at the SEC’s website at www.sec.gov or by directing a request to: info@translational-development.com.

 

4


Forward-Looking Statements

This communication contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, or the Securities Act, and section 21E of the U.S. Securities Exchange Act of 1934, as amended, or the Exchange Act, that are based on beliefs and assumptions and on information currently available to ProLogium and TDAC. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “seek” or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including the anticipated use of proceeds from the investment described herein, projections of market opportunity, number of customers or users and market share, the capability of ProLogium’s technology, ProLogium’s business plans including its plans to expand globally, the sources and uses of proceeds from the Transaction, the anticipated enterprise value of the combined company following the consummation of the Transaction, any benefits of ProLogium’s partnerships, strategies or plans as they relate to the Transaction, anticipated benefits of the Transaction and expectations related to the terms and timing of the Transaction are also forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. These statements are based on ProLogium and TDAC’s reasonable expectations and beliefs concerning future events and involve risks and uncertainties that may cause actual results to differ materially from current expectations. These factors are difficult to predict accurately and may be beyond ProLogium and TDAC’s control. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for ProLogium or TDAC to predict these events or how they may affect ProLogium or TDAC. In addition, there will be risks and uncertainties described in the proxy statement / prospectus relating to the Transaction, included in the registration statement on Form F-4 filed by ProLogium with the SEC, as amended from time to time, and other documents filed by ProLogium or TDAC from time to time with the SEC. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Neither ProLogium nor TDAC can assure you that the forward-looking statements in this communication will prove to be accurate. These forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to: the occurrence of any event, change or other circumstances that could delay, impede or prevent the business combination or give rise to the termination of the business combination; the outcome of any legal proceedings that may be instituted against ProLogium or TDAC, the combined company or others following the announcement of the business combination; the inability to complete the business combination due to the failure to obtain approval of the shareholders of ProLogium and TDAC or of the parties to satisfy other conditions to closing; the level of redemptions by TDAC’s public shareholders; the ability to maintain the stock exchange listing standards following the consummation of the business combination; the risk that the business combination disrupts current plans and operations of ProLogium or TDAC as a result of the announcement and consummation of the business combination; the ability to recognize the anticipated benefits of the business combination; costs related to the business combination; changes in applicable laws or regulations; international trade disputes, including threatened or implemented tariffs by the U.S. and threatened or implemented tariffs by foreign countries in retaliation; the ability of ProLogium to execute its business model, including market acceptance of its planned products and services; the combined company’s ability to raise capital; future financial performance of the combined company following the business combination; the possibility that TDAC or the combined company may be adversely affected by other economic, business, and/or competitive factors; risks associated with ProLogium’s efforts to commercialize its products; ProLogium’s ability to maintain its existing agreements with third parties and to negotiate and enter into new definitive agreements on favorable terms, if at all; the impact of competing products on ProLogium’s business; intellectual property-related claims against ProLogium or the combined company; ProLogium’s dependence upon its key personnel and ability to attract and retain such personnel and additional qualified personnel; ProLogium’s ability to source the raw materials for its products; the non-binding nature of the term sheets relating to certain proposed financing arrangements described herein; the risk that definitive agreements for such financing arrangements may not be negotiated or executed on the terms contemplated or at all; and the risk that, even if definitive agreements are executed, applicable funding conditions may not be satisfied or waived and the anticipated proceeds may not be received in the amounts or within the timeframe contemplated, or at all; and other risks and uncertainties set forth in the section entitled “Risk Factors” in the registration statement on Form F-4 filed by ProLogium with the SEC and those included under the heading “Risk Factors” in the final prospectus for TDAC’s initial public offering, filed pursuant to Rule 424b(4) on December 23, 2024, and its annual report on Form 10-K for year ended December 31, 2025 and in its subsequent quarterly reports on Form 10-Q and other filings with the SEC. There may be additional risks that neither ProLogium nor TDAC presently knows or that ProLogium and TDAC currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by ProLogium, TDAC, their respective directors, officers or employees or any other person that ProLogium and TDAC will achieve their objectives and plans in any specified time frame, or at all. The forward-looking statements in this communication represent the views of ProLogium and TDAC as of the date of this communication. Subsequent events and developments may cause those views to change. Except as required by applicable law, neither ProLogium nor TDAC has any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of ProLogium or TDAC as of any date subsequent to the date of this communication.

 

5


Participants in Solicitation

ProLogium and TDAC and their respective directors and executive officers may be considered participants in the solicitation of proxies with respect to the Transaction described in this communication under the rules of the SEC. Information about the directors and executive officers of TDAC and their ownership is set forth in TDAC’s filings with the SEC, including TDAC’s final prospectus for its initial public offering, filed pursuant to Rule 424b(4) on December 23, 2024, its Form 10-K for the year ended December 31, 2025 and subsequent filings under section 16 of the Exchange Act or on Form 10-Q. Additional information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of TDAC’s shareholders in connection with the Transaction is set forth in the registration statement containing the preliminary proxy statement/prospectus filed by ProLogium with the SEC. These documents are available free of charge at the SEC’s website at www.sec.gov or by directing a request to: info@translational-development.com.

No Offer or Solicitation

This communication is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Transaction and does not constitute an offer to sell or a solicitation of an offer to buy any securities of ProLogium or TDAC, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act.

 

6

Keep reading